Reply

Medical Journal of Australia

Volumn 188, Issue 7, 2008, Pages 429-430

  Mathew, Timothy H ^a   Johnson, David W ^b,c   Jones, Graham R D ^d,e  

^a Kidney Health Australia   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ENOXAPARIN; GENTAMICIN;

BODY SIZE; CHRONIC KIDNEY DISEASE; CONTINUING EDUCATION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DECISION SUPPORT SYSTEM; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG CLEARANCE; DRUG INFORMATION; GLOMERULUS FILTRATION RATE; HEALTH CARE PERSONNEL; HUMAN; INFORMATION DISSEMINATION; INFORMATION PROCESSING; LETTER; MEDICAL DECISION MAKING; MEDICAL INFORMATION SYSTEM; MEDICAL LITERATURE; ONLINE SYSTEM; PRACTICE GUIDELINE; PREDICTION;

EID: 61849094554     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Levey AS, Coresh J, Greene T, et al; Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
2. Mathew TH, Johnson DW, Jones GRD, on behalf of the Australasian Creatinine Consensus Working Group. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust 2007; 187: 459-463.
3. British National Formulary. What's new in BNF 54? Renal function and drugs. http://www.bnf.org/bnf/extra/current/450035.htm (accessed Jan 2008).
4. Thorevska N, Amoateng-Adjepong Y, Sabahi R, et al. Anticoagulation in hospitalized patients with renal insufficiency: a comparison of bleeding rates with unfractionated heparin vs enoxaparin. Chest 2004: 125: 856-863.
5. Berges A, Laporte S, Epinat M, et al. Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old. Br J Clin Pharmacol 2007; 64: 428-438.